Tag
Beryl Drugs Limited
5 articles
Beryl Drugs Board Meeting Outcomes FY2026-27
Beryl Drugs held its 1st Board Meeting of FY2026-27 on April 1, 2026, approving multiple governance and operational matters.
EOGM called to regularize appointment of Mr. Shailendra Pathak as Whole Tim
Beryl Drugs Promoter Acquires 7,500 Shares On-Market
Beryl Drugs Limited filed a SEBI Regulation 7(2) insider trading continual disclosure on 25 March 2026.
Promoter & Director Sudhir Sethi (DIN: 00090172) acquired 7,500 equity shares (0.14%) on-market
Beryl Drugs Promoter Acquires 7500 Shares Open Market
Beryl Drugs Ltd. files SEBI Regulation 29(2) disclosure for promoter Mr. Sudhir Sethi's open market share acquisition.
Sudhir Sethi acquired 7,500 equity shares (0.14%) on 24-March-2026, raising his h
Beryl Drugs Promoter Acquires 7500 Shares On-Market
Beryl Drugs Ltd discloses insider trading Form C under SEBI PIT Regulations 2015 for promoter share acquisition.
Promoter & Director Sudhir Sethi acquired 7,500 equity shares on BSE on 23 March 2026 f
Sudhir Sethi Acquires 7500 Beryl Drugs Shares
Beryl Drugs Limited discloses promoter Sudhir Sethi's acquisition of 7,500 equity shares (0.14%) via open market on 23 March 2026.
Post-acquisition, Sudhir Sethi's holding in Beryl Drugs rises from 9.